Shammaa D.; Bazarbachi A.; Halas H.; Greige L.; Mahfouz R.
(NEW ROCHELLE140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA, 2010)
Aim: The JAK2 V617F mutation has been implicated in a variety of diseases mainly related to myeloproliferative disorders including polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis with an increased ...